|
|
||||||||
Ann Thorac Surg 2000;70:2091-2095
© 2000 The Society of Thoracic Surgeons
a Department of Cardiothoracic Surgery, University of Cape Town Medical School, Cape Town, South Africa
Accepted for publication May 9, 2000.
Address reprint requests to Dr Zilla, Department of Cardiothoracic Surgery, Cape Heart Centre, University of Cape Town Medical School, Anzio Road, Observatory 7925, Cape Town, South Africa
e-mail: ctszilla{at}Samiot.uct.ac.za
Background. Fixation at high glutaraldehyde (GA) concentrations mitigated bioprosthetic calcification in the rat model. The present study intended to verify this observation in the circulatory sheep model.
Methods. Porcine aortic roots were either fixed in 0.2%, 1.0%, or 3.0% GA. Eight roots per group were implanted in the distal aortic arch of sheep. After six weeks and six months calcification and inflammation were quantitatively and qualitatively assessed.
Results. By increasing the GA concentration from 0.2% to 3.0%, aortic wall calcification could be reduced by 38% after 6 weeks and 34% after 6 months of implantation (p < 0.01). Mineralization coincided with the presence of elastin although calcium was predominantly found in cell nuclei and membranes. Leaflet calcification was absent in all groups after 6 weeks but in a few leaflets presented as heterogeneous, nodular spongiosa deposits after 6 months. Overall, differences between 0.2%-, 1.0%-, and 3.0%-fixed tissue were quantitative but not qualitative regarding distribution patterns. There was no significant difference in inflammatory host reaction between all groups.
Conclusions. We have shown in the circulatory sheep model that the anticalcific effect of better cross-linking seems to outweigh the intrinsic pro-calcific effect of GA accumulation in bioprosthetic aortic wall tissue.
This article has been cited by other articles:
![]() |
R. A. Manji, L. F. Zhu, N. K. Nijjar, D. C. Rayner, G. S. Korbutt, T. A. Churchill, R. V. Rajotte, A. Koshal, and D. B. Ross Glutaraldehyde-Fixed Bioprosthetic Heart Valve Conduits Calcify and Fail From Xenograft Rejection Circulation, July 25, 2006; 114(4): 318 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zilla, D. Bezuidenhout, and P. Human Carbodiimide Treatment Dramatically Potentiates the Anticalcific Effect of Alpha-Amino Oleic Acid on Glutaraldehyde-Fixed Aortic Wall Tissue Ann. Thorac. Surg., March 1, 2005; 79(3): 905 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Schoen and R. J. Levy Calcification of Tissue Heart Valve Substitutes: Progress Toward Understanding and Prevention Ann. Thorac. Surg., March 1, 2005; 79(3): 1072 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Human and P. Zilla Characterization of the immune response to valve bioprostheses and its role in primary tissue failure Ann. Thorac. Surg., May 1, 2001; 71 (2007): S385 - S388. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Trantina-Yates, C. Weissenstein, P. Human, and P. Zilla Stentless bioprosthetic heart valve research: sheep versus primate model Ann. Thorac. Surg., May 1, 2001; 71 (2007): S422 - S427. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |